Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Breton

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Archives Francaises De Pediatrie|August 1, 1993
[Transient neonatal hyperthyroidism caused by transplacental transport of pituitary TSH receptor antibodies]H Thibault, D Breton, R Brauner
Journal of Diabetes Science and Technology|November 11, 2015
Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 DiabetesBoris P Kovatchev, Marc D Breton
Journal of Diabetes Science and Technology|June 1, 2017
Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico StudyEnrique Campos-Náñez, Marc D Breton
Diabetes Technology & Therapeutics|September 26, 2023
Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical CareLaurel H Messer, Marc D Breton
Diabetes Technology & Therapeutics|April 24, 2020
Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network ModelsTaisa Kushner, Marc D Breton, Sriram Sankaranarayanan
Sensors (Basel, Switzerland)|December 11, 2019
Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia ContributionChiara Fabris, Basak Ozaslan, Marc D Breton
Journal of Diabetes Science and Technology|August 16, 2015
Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?Chiara Fabris, Stephen D Patek, Marc D Breton
Archives of Neurology|October 1, 1987
The GABA-agonist progabide for spasticity in multiple sclerosisR A Rudick, D Breton, R L Krall
Diabetes Technology & Therapeutics|August 28, 2013
Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patientsDayu Lv, Marc D Breton, Leon S Farhy
Diabetes Technology & Therapeutics|February 28, 2020
Impact of Daily Physical Activity as Measured by Commonly Available Wearables on Mealtime Glucose Control in Type 1 DiabetesBasak Ozaslan, Stephen D Patek, Marc D Breton
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Archives Francaises De Pediatrie|August 1, 1993
[Transient neonatal hyperthyroidism caused by transplacental transport of pituitary TSH receptor antibodies]H Thibault, D Breton, R Brauner
Journal of Diabetes Science and Technology|November 11, 2015
Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 DiabetesBoris P Kovatchev, Marc D Breton
Journal of Diabetes Science and Technology|June 1, 2017
Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico StudyEnrique Campos-Náñez, Marc D Breton
Diabetes Technology & Therapeutics|September 26, 2023
Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical CareLaurel H Messer, Marc D Breton
Diabetes Technology & Therapeutics|April 24, 2020
Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network ModelsTaisa Kushner, Marc D Breton, Sriram Sankaranarayanan
Sensors (Basel, Switzerland)|December 11, 2019
Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia ContributionChiara Fabris, Basak Ozaslan, Marc D Breton
Journal of Diabetes Science and Technology|August 16, 2015
Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?Chiara Fabris, Stephen D Patek, Marc D Breton
Archives of Neurology|October 1, 1987
The GABA-agonist progabide for spasticity in multiple sclerosisR A Rudick, D Breton, R L Krall
Diabetes Technology & Therapeutics|August 28, 2013
Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patientsDayu Lv, Marc D Breton, Leon S Farhy
Diabetes Technology & Therapeutics|February 28, 2020
Impact of Daily Physical Activity as Measured by Commonly Available Wearables on Mealtime Glucose Control in Type 1 DiabetesBasak Ozaslan, Stephen D Patek, Marc D Breton
Pageof 19